Emily Bergsland, MD

Emily Bergsland, MD

Specialty: Medical Oncology

UCSF Helen Diller Family Comprehensive Cancer Center

Multidisciplinary NET treatment program

Mission Hall, 550 16th Street Box 3211
San Francisco, California

Patient scheduling: (415) 353-9888

Online bio
90% of practice is NET patients
20 years’ experience treating NETs
52 published NET-related research papers

Emily Bergsland, MD is actively involved in neuroendocrine cancer research.

Research interests:

NET clinical trials, outcomes in NET patients, studies of NET biology

Subspecialty areas:

  • Lung NETs
  • GI NETs
  • Pancreatic NETs
  • Pheochromocytoma/Paraganglioma
  • Liver metastasis
  • Neuroendocrine carcinoma (poorly differentiated)

NET-related professional association memberships:

  • North American Neuroendocrine Tumor Society (NANETS)
  • European Neuroendocrine Tumor Society (ENETS)
  • American Association of Cancer Research (AACR)
  • NCCN NET Guidelines Panel Member

Leadership role(s):

  • North American Neuroendocrine Tumor Society (NANETS)
  • NCCN Guidelines Panel Member

NETRF-funded research

Emily Bergsland, MD,  received a 2018 NETRF Investigator Grant for the study “New strategies to improve drug development for carcinoid tumors.”

 

Presentations by Emily Bergsland, MD 

Emily Bergsland, MD, UCSF

Emily Bergsland, MD, UCSF

Understanding Clinical Trials Watch Video
Emily Bergsland, MD, UCSF

Emily Bergsland, MD, UCSF

Introduction to NETs Watch Video